Clinical Trials on Urinary Bladder Neoplasms in Belgium
Total 4742 results
-
GlaxoSmithKlineCompletedNeoplasms, Urinary BladderBelgium
-
University Hospital, GhentCompleted
-
University Hospital, GhentCompletedSurgery | Bladder Cancer | Urologic CancerBelgium
-
University Hospital, GhentTakedaCompleted
-
KU LeuvenAgentschap voor Innovatie door Wetenschap en TechnologieCompletedBladder CancerBelgium
-
University Hospital, GhentKom Op Tegen KankerRecruitingMuscle-Invasive Bladder CarcinomaBelgium
-
University Hospital, GhentActive, not recruiting
-
Jessa HospitalCompletedBladder Cancer | Antibiotic-associated Diarrhea | Antibiotic Resistant Infection | Antibiotic Resistant Strain | Antibiotic Toxicity | Prostate Hyperplasia | UrosepsisBelgium
-
Acrotech Biopharma Inc.CompletedCarcinoma, Transitional Cell | Bladder Cancer | Bladder NeoplasmSpain, France, Belgium, United States, Argentina, Croatia
-
Universiteit AntwerpenUnknownOveractive Bladder, Non Obstructive Urinary RetentionBelgium
-
Jules Bordet InstituteMerck KGaA, Darmstadt, GermanyActive, not recruitingNon-metastatic Muscle Invasive Bladder CancerFrance, Belgium
-
European Organisation for Research and Treatment...TerminatedBladder CancerNetherlands, Belgium, Italy, Turkey, Slovakia
-
Universitaire Ziekenhuizen KU LeuvenKU LeuvenRecruiting
-
University Hospital, GhentAstellas Pharma Inc; MedtronicCompleted
-
University Hospital, GhentTerminatedOveractive Bladder SyndromeBelgium
-
Universiteit AntwerpenLeiden University Medical CenterUnknownOveractive Bladder | Non Obstructive Urinary RetentionBelgium
-
Universiteit AntwerpenUnknown
-
Universiteit AntwerpenLeiden University Medical CenterUnknownOveractive Bladder | Non Obstructive Urinary RetentionBelgium
-
Association Pour La Recherche des Thérapeutiques...Roche Pharma AGCompletedRecurrent Bladder Cancer | Stage IV Bladder Cancer | Transitional Cell Carcinoma of the BladderFrance, Belgium
-
European Organisation for Research and Treatment...CompletedBladder CancerNetherlands, Belgium, United Kingdom, Italy, Portugal, Turkey
-
University Hospital, GhentMedtronicCompletedUrinary Retention | Fecal Incontinence | Overactive Bladder Syndrome | Dysfunctional Voiding | Fowler SyndromeBelgium
-
Amphora Medical, Inc.Terminated
-
Nektar TherapeuticsBristol-Myers SquibbCompletedNeoplasm Metastasis | Urinary Bladder NeoplasmUnited States, Spain, United Kingdom, Belgium, Canada, Australia, France, Italy, Greece, Germany, Portugal, Argentina, Israel, Russian Federation, Turkey, Mexico, Finland, Netherlands
-
VitadxFONDATION FORCE POUR L'INNOVATION ET LA RECHERCHE EN SANTERecruitingNon-muscle Invasive Bladder Cancer (NMIBC)France, Belgium, Spain
-
European Organisation for Research and Treatment...CompletedBladder CancerNetherlands, Belgium, France, Austria, United Kingdom, Israel, Italy, Turkey, Greece, Portugal, Romania
-
Amber Therapeutics LtdActive, not recruiting
-
Axonics Modulation Technologies, Inc.CompletedOveractive BladderNetherlands, France, Belgium, United Kingdom
-
Universiteit AntwerpenRecruitingOveractive Bladder | Voiding Disorders | Pelvic Organ Prolapse | Stress Urinary Incontinence | Urge IncontinenceBelgium
-
PfizerCompletedNeurogenic Detrusor OveractivityBelgium
-
Astellas Pharma Europe B.V.Veeda Clinical ResearchCompletedLower Urinary Tract Predominant Storage SymptomsBelgium
-
UNICANCERHoffmann-La RocheActive, not recruitingBladder CancerSpain, France, Belgium
-
University Hospital, GhentAlgemeen Ziekenhuis Maria Middelares; AZ Sint-Lucas Gent; AZ Jan Palfijn GentNot yet recruitingOveractive Bladder | Sacral Neuromodulation | Diversity | Onabotulinum Toxin A | Discrete Choice ExperimentBelgium
-
ADC Therapeutics S.A.TerminatedBreast Cancer | Non Small Cell Lung Cancer | Bladder Cancer | GastroEsophageal CancerUnited States, Belgium
-
Hoffmann-La RocheCompletedBladder CancerUnited States, France, Belgium, Korea, Republic of, United Kingdom, Czechia, Austria, Canada, Denmark, Greece, Italy, Netherlands, Portugal, Slovenia, Spain, Sweden, Turkey, Poland, Hungary, Switzerland, Japan, Taiwan, Australia, Norway, Germa... and more
-
National Multiple Sclerosis CenterTerminatedInterstitial Cystitis | Painful Bladder SyndromeBelgium
-
Astellas Pharma IncCompletedOveractive Bladder | Neurogenic Detrusor OveractivityBelgium, Canada, Denmark, Netherlands, Poland, Turkey, United Kingdom
-
AllerganCompletedOveractive Bladder | Urinary IncontinencePoland, Germany, United States, Canada, United Kingdom, Belgium
-
Astellas Pharma IncCompletedUrinary Bladder, OveractiveSweden, United Kingdom, Belgium, Denmark
-
PfizerCompletedNeurogenic Detrusor OveractivityBelgium
-
Bristol-Myers SquibbNektar TherapeuticsCompletedBladder Cancer | Bladder Tumor | Muscle-Invasive Bladder CancerRussian Federation, China, Germany, Italy, United States, Argentina, Australia, Austria, Belgium, Brazil, Canada, Czechia, France, Greece, Israel, Mexico, Netherlands, Poland, Spain, United Kingdom
-
AllerganCompletedOveractive BladderPoland, United Kingdom, Belgium, Russian Federation, Czech Republic, Germany, United States
-
Astellas Pharma IncAstellas Pharma Europe B.V.CompletedOveractive Bladder | Pharmacokinetics of Mirabegron | Neurogenic Detrusor OveractivityBelgium, Denmark, Norway, Poland, Serbia
-
AstraZenecaCompletedPancreatic Ductal Adenocarcinoma | Triple-negative Breast Cancer | Urothelial Bladder CancerUnited States, Belgium, Korea, Republic of, Poland, Netherlands
-
University of ZurichRecruitingNeurogenic Bladder DysfunctionBelgium, Brazil, Italy, Switzerland
-
MedtronicNeuroTerminatedUrinary Incontinence | Detrusor Overactivity | Neurogenic Overactive BladderBelgium, France, United Kingdom, Germany, Italy, Netherlands
-
SanofiCompletedUrinary Bladder NeoplasmsBelgium, Mexico, Brazil, Chile, Poland, South Africa, Spain, Israel, United States, Argentina, Australia, Canada, France, India, Italy, Netherlands, Russian Federation, Sweden, Turkey
-
AstraZenecaActive, not recruitingNon-muscle-invasive Bladder CancerFrance, Spain, Belgium, Canada, Poland, Germany, Japan, Russian Federation, United Kingdom, Austria, Australia, Netherlands
-
Hoffmann-La RocheRecruitingMuscle-invasive Bladder CancerBelgium, Korea, Republic of, Japan, Brazil, China, United States, Singapore, France, United Kingdom, Canada, Greece, Italy, Spain, Turkey, Russian Federation, Ukraine, Israel, Czechia, Colombia, Hong Kong, Argentina, Germany, Ireland, Polan... and more
-
Universiteit AntwerpenRecruitingOveractive Bladder | Lower Urinary Tract Symptoms | Enuresis | Voiding DisordersBelgium
-
AstraZenecaActive, not recruitingMuscle Invasive Bladder CancerUnited States, Belgium, France, Germany, Italy, Spain, United Kingdom, Canada, Poland, Taiwan, Vietnam, Turkey, Korea, Republic of, Brazil, Czechia, Japan, Philippines, Israel, Chile, Australia, Netherlands, Russian Federation